Clinical trial
A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema
NCT00168389 · Allergan, Industry · Completed
Key facts
| NCT number | NCT00168389 |
|---|---|
| Title | A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema |
| Lead sponsor | Allergan, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Macular Edema |
| Intervention type | Drug, Other |
| Interventions | Dexamethasone, Sham |
| Enrollment | 494 |
| Start date | Feb 1, 2005 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Sep 15, 2005 |
| Last update posted | Aug 4, 2014 |
| Countries | Australia, Canada, Czechia, Germany, Israel, Philippines, Portugal, South Africa, Spain, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: